Aconitinum
V - Various
ATC V60
Small molecule
Natural product
JFDA label: Meditonsin
Chemistry & Properties
| Formula | C34H47NO11 |
|---|---|
| Molecular weight | 645.75 g/mol |
| IUPAC name | [(1S,2R,3R,4R,5R,6S,7S,8R,9R,13R,14R,16S,17S,18R)-8-acetyloxy-11-ethyl-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate |
| CAS | 302-27-2 |
| PubChem CID | 245005 |
| InChIKey | XFSBVAOIAHNAPC-NPVHKAFCSA-N |
| logP | 0.65 (XLogP 0.3) |
| Polar surface area | 153.45 Ų |
| H-bond acceptors / donors | 12 / 3 |
| Drug-likeness (QED) | 0.32 |
| Lipinski violations | 2 |
SMILES
CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@@H]14)[C@@H](O)[C@@H]6OCBiology & Pharmacokinetics
Pharmacokinetics predicted
| Bioavailability | 70.0% |
|---|---|
| Half-life | 2.044 h |
| Volume of distribution | 0.856 L/kg |
| Protein binding | 45.1% |
| BBB penetrant | Yes |
Enzyme interactions
| Enzyme | Role | Detail |
|---|---|---|
| CYP2B6 | Inhibitor | — |
| CYP2C8 | Inhibitor | — |
| CYP3A4 | Substrate | — |
Transporters
BCRP (Inhibitor)BSEP (Inhibitor)MRP1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)
Registered Products (1)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
|---|---|---|---|---|
| Meditonsin | Cream 1 g, 5 g, 4 g | 35gm | Karmel Drug Store | 5.500 |